Regarding SIRT5 activators, MC3138, a selective SIRT5 activator, mimicked the effects of SIRT5 overexpression-mediated deacetylation and desuccinylation in pancreatic cancer cells, leading to reduced levels of metabolites such as glutamine and glutamate (168). Here, SIRT5 is linked to pancreatic neoplasm.